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ABSTRACT  
Cancer patients rate rapid diagnosis as one of the most important aspects of their hospital-based care, 
but very little research has examined the psychological implications of diagnostic delay. Diagnostic 
delay can have both short and long-term effects on a patient’s psychological wellbeing, quality of 
life, and satisfaction with care, as a result of what happens during the pre-diagnostic period, and the 
consequences any delay may have on the patient’s prognosis and treatment.  
A third of patients undergoing investigations for suspected cancer have clinically significant levels of 
distress, and both distress and quality of life during this time are similar to people with a confirmed 
diagnosis of cancer. Patients who experience diagnostic delay also have a higher number of 
consultations and medical tests and are more likely to experience substandard quality care, but the 
effect of this on psychological outcomes among both patients and family members remains 
underexplored. Patients undergoing investigations for suspected colorectal cancer have informational 
and emotional needs, some of which remain unmet. Population subgroups that may be particularly 
vulnerable to distress during the diagnostic phase include women, younger adults, and people with 
lower social support, low optimism, and high intolerance of uncertainty. 
Further research is needed into the effect of rapid diagnostic pathways on psychological outcomes, 
but also needs to explore the role of particular experiences during the diagnostic phase, such as 
number of consultations and diagnostic errors on patient wellbeing, and not just time to diagnosis.  
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INTRODUCTION 
Cancer patients rate rapid diagnosis as one of the most important aspects of their hospital-based care 
(1), but while a great deal of research has examined the prognostic implications of diagnostic delay, 
very little has examined its psychological consequences. Diagnostic delay, which can include patient 
delay in seeking help as well as time from first contact with health care until a diagnosis is 
established, can have both short and long-term effects on a patient’s psychological wellbeing, quality 
of life, and satisfaction with care, as a result of what happens during the pre-diagnostic period, and 
the consequences any delay may have on the patient’s prognosis and treatment.  
 
THE PRE-DIAGNOSTIC PHASE 
During the pre-diagnostic phase, people with symptoms suspicious of cancer face the threat of 
serious illness while having to undergo invasive medical tests, which may be uncomfortable or 
frightening, and attend numerous appointments. Some may also experience substandard care that 
directly contributes to a delay in their diagnosis.  
 
Distress and quality of life  
Receiving the diagnosis has been rated as the most stressful aspect of having cancer among breast 
cancer patients, but periods of waiting were also high on the list (2). In a review of research into 
distress in the diagnostic phase, Brocken et al (3) found between 33-60% of patients undergoing 
investigations for cancer (breast, malignant melanoma, ovarian, prostate, and lung) reported clinical-
levels of anxiety prior to diagnosis (i.e. high enough to be classified as an anxiety disorder using 
psychiatric assessment tools). While most studies found anxiety reduced in people with benign 
outcomes, anxiety levels were sustained or increased in people diagnosed with cancer. Although a 
couple of studies showed a reduction in anxiety following a cancer diagnosis (in patients with 
melanoma (4) and ovarian cancer (5)), both samples were small, and in the latter study baseline 
anxiety was measured prior to surgery probably inflating baseline scores.  
Suspected cancer patients also reported poorer quality of life than members of the general 
population, with some studies showing poorer quality of life in the pre-diagnostic phase compared 
with post-diagnosis, while other studies showed no change post-diagnosis, regardless of whether the 
outcome was benign or malignant (3). On the basis of their review, Brocken et al (3) conclude that 
patients with suspected cancer have similar or worse levels of anxiety and quality of life than patients 
with a confirmed diagnosis of cancer.  
The majority of the studies included in Brocken et al’s review were on patients with suspected breast 
cancer, with none on people under investigation for colorectal cancer. Similar rates of post-
diagnostic distress have been reported in breast and colon cancer patients (32.8% for breast and 
31.6% for colon) (6), suggesting similar pre-diagnostic rates might also be expected. A more recent 
study in Denmark, of consecutively recruited patients onto a cancer patient pathway (which would 
have included people with suspected colorectal cancer), reported similar rates of distress as Brocken 
et al (3), with one third of patients reporting clinical levels of anxiety during the pre-diagnostic 
phase. Consistent with previous findings, they also observed reductions in anxiety and improvements 
in quality of life and symptomatology among those receiving a non-cancer diagnosis, with no change 
in these variables among patients diagnosed with cancer (7).  
A study conducted in Canada on patients with a confirmed diagnosis of colorectal cancer attending 
clinics for follow-up care, asked patients about their specific needs during the pre-diagnostic phase. 
The study found that patients reported high anxiety levels during this time, and the most frequently 
identified needs were informational and emotional, reported by 31.6% and 20.3% respectively (8). 
Although the majority (84%) said their needs had been met, a high proportion of patients (77.9%) 
also reported that they had not been directed to any sources of help in coping with their anxiety 
during the pre-diagnostic phase, suggesting patients require more emotional support during this time. 
In addition patients were most likely to report needing more information after receiving test results. 
 
 
Rapid diagnosis and feedback 
Research has also examined whether speeding up the diagnostic process improves psychological 
outcomes. Prompt feedback of test results is clearly important to patients. Patients with symptoms of 
suspected colorectal cancer report higher levels of satisfaction with the way test results are conveyed 
when results are given following colonoscopy, where results are often given immediately and face to 
face, rather than CT colonography, where there is a delay due to the need for radiological reporting 
of results (9). However, the majority of this sample did not have cancer and rapid feedback may be 
valued differently by people with benign versus malignant outcomes. Among people ultimately 
diagnosed with cancer, a more rapid diagnosis means a speedier transition from healthy person to 
patient. As a result, people have less time to prepare for bad news which may adversely affect their 
psychological wellbeing. On the other hand, it reduces the period of uncertainty which may be 
beneficial, particularly for people who find uncertainty difficult to manage.  
There is limited evidence that rapid diagnostic pathways, e.g. one or two-stop shops, can improve 
psychological outcomes. In their review,  Brocken et al (3) found rapid pathways reduced the period 
of distress among those found to have benign disease, with no evidence of benefit, or harm  among 
those diagnosed with cancer (3). Although one study, comparing women diagnosed with breast 
cancer at a one-stop shop vs. a two-stop system, found higher levels of depression among women 
attending the one-stop shop eight weeks later, differences were small (10) and not considered 
clinically significant (3). In addition, depression was measured from the date of the biopsy, and not 
from the date at which women were told of their diagnosis, so women in the one-stop shop had 
known about their diagnosis for one week longer which might account for the differences between 
the two groups.  A more recent study, albeit among lung cancer patients, did find evidence of short-
term benefit, with lower distress associated with a more rapid diagnosis among both patients with 
benign and malignant outcomes, although this benefit was no longer apparent 3 months later (11).  
The review by Brocken et al (3) excluded studies on cancer screening, but research in this area 
suggests that rapid diagnosis is beneficial to patients. Qualitative research into the experience of 
having colorectal cancer (CRC) detected at flexible sigmoidoscopy screening found that many 
people described the diagnosis as relatively untraumatic,  due to the absence of a period of symptoms 
and associated worry about a potential cancer diagnosis, and the need for simpler treatment which 
often comprised surgery alone (12). In addition, a cross-sectional study on colorectal cancer 
survivors in Scotland, between 3.5 and 12 years post-diagnosis, showed people with screen-detected 
disease reported lower levels of perceived diagnostic delay and better quality of life than people 
diagnosed symptomatically (either following a negative screening result or because screening was 
not offered), even when demographic, and prognostic factors were controlled for, although actual 
delay was not measured (13). Although people with interval cancers are more likely to have right-
sided disease (14), there were no differences in perceived diagnostic delay or quality of life among 
people with interval cancers compared with people whose cancers had been diagnosed in a 
geographical area not offering screening at that time. The same data showed that higher levels of 
perceived diagnostic delay were associated with greater cancer-related distress and more suspected 
cases of post-traumatic stress disorder (PTSD). Part of the relationship between perceived delay and 
cancer-related distress was explained by quality of life, but not by disease stage at diagnosis, or 
treatment received (15).  The exact reasons for the relationship between perceived diagnostic delay 
and cancer-related distress were unclear, and could relate to the traumatic experiences associated 
with delay. When it comes to experiencing cancer as a traumatic stressor, criteria for PTSD (in 
DSM-5) specify that “Medical incidents that qualify as traumatic events involve sudden, catastrophic 
events”.  The need for emergency admission to hospital, or the discovery that their cancer has been 
misdiagnosed by their primary healthcare provider or missed by previous investigations, could 
contribute to the development of distress or trauma.  
 
Consultations, investigations and diagnostic delay 
Diagnostic delay does not just mean a longer period of waiting for a diagnosis, it is also associated 
with a greater number of medical consultations and investigations. A UK-based study showed 
diagnostic delay was associated with a higher number of consultations with a primary care provider 
prior to referral to a specialist, with 20% of patients ultimately diagnosed with colorectal cancer 
having 3 or more visits before being referred (16). The main predictor of number of consultations 
was cancer type, attributed to the non-specific nature of symptoms associated with some cancers 
more than others, making them harder to diagnose, with colorectal cancer classified as being of 
intermediate diagnostic difficulty (17).  
People who experience a delay in their diagnosis also undergo a greater number of diagnostic tests 
than those who are dealt with promptly (16). Undergoing additional tests may contribute to patients’ 
psychological burden, over and above extending the waiting time for a diagnosis. Concern over test 
results has been cited as the most common cause of anxiety in patients waiting for diagnostic 
procedures in an oncology clinic (18), but undergoing procedures involves a number of additional 
challenges. Diagnostic tests and further investigations for colorectal cancer such as colonoscopy, 
computed tomographic (CT) colonography and MRI can be uncomfortable as well as anxiety-
inducing (e.g. (9, 19)). Patients may need to undergo bowel preparations; injections, some involving 
radioactive ligand (e.g. PET-CT) which may promote fears about radiation risk; as well as scans, 
such as MRI which are noisy and require full body immersion into a relatively narrow tube, causing 
anxiety and claustrophobia in a substantial proportion of patients (19, 20).  
Diagnostic delay can also impact patient satisfaction with their care, particularly if the patient 
believes the delay was due to lack of action by a physician or felt the wait for tests or referrals had 
been too long (21). A greater number of visits prior to diagnosis is associated with lower patient 
satisfaction with care (21). In addition, patients who reported that the time between seeking help and 
confirmation of cancer diagnosis was ‘about right’ vs. ‘a bit long’ vs. were more likely to report that 
they were satisfied with the communication around cancer diagnosis, prognosis and treatment (75% 
vs. 41% reporting high-mid levels of satisfaction) (22). In a study on patients with anal cancer, Chui 
et al found that any delay was associated with reduced satisfaction but this was much greater if the 
patients believed the cause of that delay was the fault of the medical profession rather than the 
patient failing to seeking medical help promptly (21). 
Although there are a number of factors influencing diagnostic delay, in some cases patients may have 
good reason to believe any delay in diagnosis is the result of substandard medical care. Initial 
misdiagnosis (treating the symptoms, or attributing symptoms to a disease other than colorectal 
cancer), failure to examine the patient, and negative or false negative results have all been associated 
with increased diagnostic delay (23).  A retrospective review of colorectal cancer miss rate in a 
district general hospital in the UK found an 8% false negative rate across three investigative 
modalities (double contrast barium enema, colonoscopy and computed tomographic colonography) 
with lowest rates for colonoscopy and highest for barium enema (24). The psychological 
consequences of misdiagnoses and false negatives are under-explored. One study on the 
consequences of a false negative in FOBt colorectal cancer screening in Scotland found no evidence 
of poorer psychological outcomes following a ‘missed’ cancer compared to people who had been 
diagnosed in the absence of an invitation to undergo screening (10), with no significant differences 
between the two groups on measures of perceived diagnostic delay, quality of life or depression,  
however the study was conducted during the pilot phase of FOBt screening and patient expectations 
about test performance may have been lower than for an established screening service.  
Research into GP and patient perspectives on so-called “quality deviations” (QD) (defined as an 
event ‘that should not have happened and that you don’t want to happen again’), showed GPs in 
Denmark rated one third of cancer patients as having a QD, with longer diagnostic delay associated 
with GP report of a QD (25). Although both GPs and patients reported a similar proportion of QDs, 
they showed poor levels of agreement about what counted as a deviation. Reports of a QD by GPs 
were more strongly associated with diagnostic delay (time elapsed) than patient reports of QD (26), 
suggesting that for patients, quality of care is more strongly associated with factors other than length 
of time to diagnosis.  
 
Emergency presentation 
Emergency presentation of colorectal cancer is associated with more advanced disease at diagnosis 
and lower survival rates (27), and a quarter of colorectal cancers in England are diagnosed via this 
route (28). Even after adjusting for disease stage, emergency presentation is associated with higher 
mortality and shorter disease-free survival, suggesting such patients have more aggressive tumour 
biology (e.g. extramural vascular invasion) (29). Although conclusive data supporting the role of 
diagnostic delay in emergency presentations is lacking (28), rates of emergency presentation vary 
across primary health care providers suggesting some variability is attributable to patient and 
provider factors (27). Patients who present via an emergency route in England are significantly less 
positive about their care than those who present through a planned cancer pathway (30). This is 
perhaps unsurprising given that such patients are also more likely to present with pain and 
obstruction (28) have longer surgeries, longer admissions and more readmissions (29). However the 
psychological consequences of emergency presentation among cancer patients has not been explored.  
 
  
Vulnerability and resilience 
Few studies have examined predictors of emotional wellbeing during the pre-diagnostic phase. 
However studies on predictors of anxiety or depression after a cancer diagnosis show certain sectors 
of the population are more vulnerable, for example, people with a family or personal history of 
psychiatric disorder, people with low socio-economic status, women, and those of a younger age (7, 
31-33). Intolerance of uncertainty, defined as a tendency to react negatively to uncertain situations 
(34), is associated with higher levels of negative affect such as fear and worry in the short-term and 
is also a risk factor for the development of pathological anxiety (35). In addition it has been shown to 
correlate with higher anxiety among men with low risk prostate cancer, undergoing active 
surveillance of their condition (36), as well as higher depression and poorer emotional wellbeing 
among lung cancer patients (37). This research suggests that diagnostic delay, and the associated 
period of uncertainty, may be particularly detrimental to people who find uncertainty difficult to 
manage and further research should be directed at understanding subgroups who may be particularly 
vulnerable to distress in the pre-diagnostic phase.  
Research on resilience, defined as “healthy adaptation in the context of adversity”, has also been 
limited to the study of how people cope with cancer (38-40) rather than coping in the pre-diagnostic 
phase, although diagnostic workup of symptoms has been identified as one of the many events 
people with cancer have to deal with (41). In their model of resilience in cancer, Deshields et al (41) 
propose that personal attributes and environmental circumstances influence how individuals respond 
initially along the distress-resilience continuum, but that this initial response can be “recalibrated”, 
either as a result of the individual’s coping responses or through psychological interventions. Factors 
such as older age, male gender (42), optimism and social support (43) are associated with greater 
resilience. While the absence of other stressors is also beneficial (44), there is evidence for “stress-
induced resilience”: a study on breast cancer survivors showed moderate acute stress was associated 
with greater resilience, while either low or high levels of acute stress prior to a cancer diagnosis was 
associated with lower resilience (45). Interventions that can be used to foster resilience include 
promoting emotional expression, reminding people of their previous successful coping efforts in the 
face of difficulties, and cognitive-behavioural therapy focused on reducing worry (41) (also see 
(43)). 
 
Summary 
Research to date shows a substantial proportion of people undergoing investigations for cancer have 
higher levels of distress and poorer quality of life than the general population, with rates similar to 
people with a confirmed diagnosis of cancer. Patients who experience diagnostic delay have a higher 
number of consultations and medical tests and are more likely to experience substandard quality 
care. Further research is needed into patient experiences during the pre-diagnostic phase that may 
affect psychological wellbeing and quality of life, including what procedures and diagnostic routes 
people take, as well as their perceptions of what counts as efficient and good quality care, and 
identify and provide support for areas of unmet need. More research needs to be done to identify 
vulnerable subgroups of the population and offer support where necessary. For example, cognitive-
behavioural treatments can help reduce intolerance of uncertainty, through techniques aimed at 
getting people to recognise, accept and deal with uncertainty (46) and greater psychological support 
for people undergoing investigations for cancer could help patients cope better with the difficulties 
they face during the pre-diagnostic phase.  In addition, although research has examined the 
psychological impact of cancer on family caregivers across the cancer trajectory, this has typically 
focused on the point of diagnosis onwards (47), with little work examining the impact of the 
diagnostic phase on family members. Although a recent study has examined patient and carer 
perspectives on a lung cancer diagnosis following emergency admission (48), the research focussed 
on lay understanding of symptoms and help-seeking behaviours before hospital admission, rather 
than the psychological impact of a delayed diagnosis. 
A summary of prediagnostic variables, and psychological effects is in Table1.  
 Table 1: Summary of the psychological implications of different aspects of diagnostic delay  
 
Prediagnostic variables Psychological effect 
Length of time Prolongs period of anxiety and poor quality 
of life among both people found to have 
cancer and those with benign disease.  
Increased number of consultations and 
diagnostic tests 
May increase anxiety. Reduces patient 
satisfaction with care. 
Malpractice  Little research on psychological impact. 
More advanced disease at diagnosis Associated with increased anxiety, 
depression, greater likelihood of post-
traumatic stress disorder and poorer quality 
of life. 
Premorbid factors  Little research on factors specifically 
associated with poorer psychological 
outcomes in the diagnostic phase. 
Emergency presentation Reduces patient satisfaction with care but 
little research on psychological impact. 
Information  Limited evidence suggests patients need 
additional information particularly after they 
have received test results. 
 
THE POST-DIAGNOSTIC PHASE  
Colorectal cancer survivorship can be affected by emotional difficulties; bowel, urinary and sexual 
problems; negative body image; and fear of recurrence with such problems impacting on the 
patient’s social life and ability to work (49). Such problems can be exacerbated by later disease stage 
at diagnosis or the receipt of adjuvant therapies. Detection of colorectal cancer via screening in 
asymptomatic patients picks up cancers at an earlier stage and leads to a reduction in mortality (50) 
showing that earlier detection can improve prognosis. However the relationship between diagnostic 
delay and stage at diagnosis in patients with symptomatic colorectal cancer is complex, with both 
short and long delay associated with higher mortality (51). While some studies have found no 
association between delay and mortality, the possibility that longer diagnostic delay did not impact 
on mortality could not be excluded (e.g. (52)). 
 
Stage, treatment and emotional difficulties 
Emotional difficulties following a cancer diagnosis include depression, anxiety, and stress-related 
responses including post-traumatic stress disorder (PTSD). Such difficulties are often comorbid 
 among cancer survivors (53). A recent meta-analysis of the prevalence of anxiety and depression 
among people two or more years post-diagnosis found anxiety rates of 17.9% (95% CIs: 12.8 to 
23.0) and depression rates of 11.6% (95% CIs: 7.7 to 16.2) (54). A large study of patients with 
colorectal cancer attending cancer clinics in Scotland found marginally lower rates of depression at 
7% (95% CI: 6.1-8), with higher rates among women, younger patients, and people with higher 
levels of deprivation (32). Rates of anxiety were not examined. Although symptoms of full- PTSD 
are typically less frequent than those of depression and anxiety, they are found in a significant 
minority of cancer survivors (e.g. 6.4% point prevalence, with a lifetime risk of 12.6% (55)) 
Rates of emotional disorders such as depression and post-traumatic stress disorder are higher among 
cancer survivors than people with no history of the disease (56, 57), and patients with more advanced 
disease are more likely to report high distress (58) and the presence of PTSD (55, 59) than patients 
with earlier disease stage at diagnosis. Although distress tends to be higher shortly after patients 
learn the diagnosis than at later stages in their disease trajectory (22, 60), patients display different 
emotional trajectories over time. A longitudinal, prospective study in Australia examined distress in 
colorectal cancer patients from 5 months to 5 years post-diagnosis. The authors used the Brief 
Symptom Inventory-18 (a measure combining anxiety, depression and somatisation) and  identified 
four different patterns of distress over time: consistently low distress (experienced by 19.4% of the 
sample), medium level distress (going from case to non-case, experienced by 29.4%), medium 
increase distress (going from non-case to case, experienced by 38.5%), and high distress (remaining 
at case level across time, experienced by 12.5%) (58).  The odds of being in a distress trajectory 
other than the consistently low one was higher for patients with later stage disease –stages III or IV 
compared with stages 0,I or II (controlling for age, gender, educational level and social support). 
Although treatment type was a significant predictor of distress group in unadjusted analysis, it was 
not significant when other variables were added into the model. Examination of the different 
subscales found disease stage also predicted poorer trajectories of anxiety and somatisation although 
not depression.  
 
Patients with more advanced disease are more likely to receive chemotherapy and radiotherapy, and 
higher anxiety, depression and symptoms of traumatic stress have been observed in patients who 
have chemotherapy or radiotherapy in addition to surgery compared with those having surgery alone 
(61), although this study did not examine the effect of disease stage independently of treatment 
received.  
Qualitative research on the concerns of Stage II and stage III colorectal cancer survivors who had 
completed active treatment, found higher distress was associated with treatment-related toxicities 
such as peripheral neuropathy (numbness/ tingling in the hands and feet), a side-effect of the 
chemotherapy drug oxaliplatin, and major challenges in daily activities particularly around caring for 
their colostomy (62). Oxaliplatin causes neuropathy in the majority of patients during the therapy 
itself, with 12% of patients experiencing persistent neuropathy 4 years after treatment (63). Severe 
peripheral neuropathy during treatment has been associated with higher rates of depression and 
anxiety, and poorer sleep quality (64), impacting on people’s ability to carry out everyday activities 
as well as work (65).  
A study on symptoms among colorectal cancer patients undergoing chemotherapy, found they 
reported an average of ten symptoms, with the most common being peripheral neuropathy (64 %), 
lack of energy (62 %), feeling drowsy (49 %), and nausea (45 %), with lack of energy being one of 
the symptoms patients found most distressing (66). In a large sample study of outpatient cancer 
patients with different types of cancer attending a regional centre in Scotland, clinically relevant 
fatigue (defined as fatigue worthy of further clinical attention) was reported by 33% of colorectal 
cancer patients. Across the sample of mixed cancer sites as a whole, both presence of local and distal 
disease, and receipt of radiotherapy or chemotherapy in the previous two months, were 
independently associated with a higher likelihood of fatigue, with the majority of respondents not in 
active treatment (67). Such symptoms can impact patient distress, with this research also showing the 
presence of fatigue was associated with higher levels of distress (measured by the HADS) (67).  
 
Stage, treatment and quality of life 
Quality of life typically comprises the patient’s subjective assessment of their physical, functional, 
psychological, and social wellbeing, and as such overlaps with emotional outcomes and symptoms. 
Poorer quality of life is often reported among patients with more advanced disease (e.g. (68, 69). 
While Foster et al (70) found no relationship between disease stage at diagnosis and quality of life, 
people with advanced disease (stage IV) were excluded from the study.  
As with emotional outcomes, trajectories of quality of life in colorectal cancer survivors have been 
shown to vary across individuals. In a related study to the one reported earlier on trajectories of 
distress, Dunn et al (69) looked at quality of life over time from 5 months to 5 years post-diagnosis 
(assessed using the FACT-C, which contains physical, functional, social/family, emotional wellbeing 
and colorectal cancer specific symptom subscales), and found four different trajectories: constant 
high quality of life (26.2%), constant medium (47.1%), medium decrease showing dramatic decrease 
in quality of life two years post-diagnosis (7.4%), and constant low quality of life (19.2%). Again, 
disease stage, but not treatment received, predicted membership of the quality of life trajectories 
‘medium decrease’ and ‘constant low’  compared with reference category of ‘consistently high’ 
quality of life. Neither disease stage nor treatment received predicted membership of the trajectory 
‘constant medium’ compared with the trajectory of ‘constant high’ quality of life  (69). However 
other studies show links between specific treatments and their associated sequelae and quality of life.  
Treatments such as radiotherapy can increase the risk of bowel and urinary incontinence (71). 
Patients with diarrhoea have reported poorer quality of life 6 weeks after potential curative surgery 
for colorectal cancer (72) and in the longer term (56). In a systematic review of quality of life in 
long-term colorectal cancer survivors (5 or more years post diagnosis) Jansen et al (56) found overall 
quality of life was comparable with the general population with some evidence of slightly lower 
physical quality of life in colorectal cancer survivors. However quality of life was lower among 
patients with bowel problems such as diarrhea (e.g. (73)). Pollack et al (71) looked at patients who 
had previously taken part in a randomised controlled trial (an average of 15 years ago, to establish 
whether preoperative radiotherapy reduced local recurrence in rectal cancer patients). They found 
higher levels of faecal and urinary incontinence and diarrhoea in patients receiving radiation 
compared to those having surgery alone, although only among patients who had not had a stoma. 
One risk factor for non-reversal of temporary stomas is more advanced disease (74). Stoma-related 
complications, such as leakage, have been reported in over 40% of patients (74, 75);  and stomata 
can have adverse effects on quality of life (56, 70, 76) and impact on the patient’s body image and 
sexual function (77).  
Research consistently shows an adverse effect of radiotherapy on long-term bowel and sexual 
functioning, but evidence concerning the long-term adverse effects of chemotherapy is mixed. For 
example, Arndt et al (78) found chemotherapy recipients reported poorer role and social functioning 
1-3 years post-diagnosis, while others found no association between receipt of chemotherapy and 
quality of life (e.g. (79). These differences may be due to the age group being studied as more 
pronounced deficits are typically observed among younger age groups (e.g. under 70 (80))  
Perceived quality of care at the time of cancer treatment (i.e. treatment information problems, 
problems with the control of nausea and vomiting, and pain and discomfort) has also been shown to 
predict subsequent quality of life in colorectal cancer patients, controlling for demographic and 
clinical variables (81) highlighting the importance of patient-centred care during treatment for 
cancer.   
Fear of recurrence, social distress and ability to work 
Among colorectal cancer survivors, five or more years post-diagnosis, between one quarter and one 
third of patients report concerns about recurrence (27-33%), and worry about developing another 
type of cancer (26-30%); with a higher proportion reporting concerns about symptoms indicating a 
recurrence (34-41%) and worry about future diagnostic tests (41-44%) (82). In a study conducted in 
the Netherland, fear of recurrence in colorectal cancer survivors was not associated with disease 
stage or treatment (83). However it was associated with distress and quality of life, and indirect 
relationships between disease stage and treatment on fear of recurrence via distress and quality of life 
are a possibility, and remain to be explored. 
Some procedure-related concerns, such as the effects of cancer risk caused by ionising radiation 
associated with medical imaging, become more apparent in the post-treatment phase, while patients 
earlier on in the treatment process are more concerned with surviving the initial disease (84). This 
raises the possibility that an increased number of diagnostic tests may add to the worries patients 
experience after treatment has ended. 
Disease stage at diagnosis and the type of treatment patients receive can also have wider impact. 
Social distress (indexed by concerns about everyday living, money worries, and concerns about 
oneself and other people) 12-36 months after a colorectal cancer diagnosis was higher among people 
with more advanced disease, those with recurrent or non-treatable disease, patients with a stoma, and 
among patients who had had radiotherapy (85). Gastrointestinal cancer survivors are more likely to 
be unemployed than people with no history of the disease (48.8% vs. 33.4%). Reasons given by 
cancer survivors for unemployment included physical limitations, and/ or cancer-related symptoms 
(86). In addition, the treatment the patient receives also impacts on the psychological wellbeing of 
family care-givers, for example Graca-Pereira et al (61) found higher anxiety and traumatic stress 
among partners of patients who had chemotherapy or radiotherapy in addition to survey vs surgery 
alone.  
Summary 
Later disease stage at diagnosis adversely affects emotional and quality of life outcomes in colorectal 
cancer survivors. Adjuvant treatments, such as radiotherapy and chemotherapy can cause long-term 
symptoms such as diarrhoea or peripheral neuropathy that can also impact on patient’s quality of life 
and distress. In addition, having a stoma can adversely affect body image, although may reduce 
rectal symptoms, leaving the overall effect of having on stoma on quality of life unclear. Although 
associations between diagnostic delay and disease stage at diagnosis remain unclear, with more convincing 
associations for rectal compared with colon cancer (87), it remains a possibility that a delay in diagnosis of 
colorectal cancer may result in more advanced disease and the need for adjuvant treatments, both of which 
adversely affect people’s emotional and physical wellbeing for years after the initial diagnosis.  
 
Conclusion 
Undergoing investigations for cancer can be stressful, and rates of distress and poor quality of life 
among patients with suspected cancer are the same as those with a confirmed diagnosis. Rapid 
diagnostic pathways will reduce the period of distress for people eventually diagnosed with benign 
disease, and may also benefit people ultimately diagnosed with cancer, although further research is 
needed to confirm this. However, patients who experience diagnostic delay do not simply wait longer 
for a diagnosis, they also have a higher number of consultations and medical tests and are more 
likely to experience substandard quality care, which impacts on patient satisfaction. The 
psychological consequences of these experiences have been underexplored, and research into which 
sectors of the population are most vulnerable to adverse outcomes arising from delay is also lacking. 
Priority areas for future research are summarised in Table 2. 
 
Table 2 Priority areas for future research 
 
Suggested priority of further research on psychological aspects of diagnostic delay in 
CRC 
The impact of rapid diagnostic pathways on psychological wellbeing among people 
diagnosed with colorectal cancer 
Better understanding of patients’ views about the relative importance of time to diagnosis 
versus quality of care. 
Effect of particular experiences associated with diagnostic delay, such as number of 
investigations and consultations, as well as medical errors, and not just time to diagnosis, on 
psychological wellbeing and quality of life. 
The role of demographic and psychological factors in vulnerability to distress in the 
diagnostic phase, such as age, gender, socio-economic status, history of mental illness and 
intolerance of uncertainty. 
The impact of diagnostic delay on friends and family. 
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